TP53 is the most frequently mutated gene in human cancer, with both loss-of-function and gain-of-function mutations that can alter cell cycle regulation, apoptosis, senescence, DNA repair, and accumulate genetic alterations [126,127]. This evidence concerns the gene TP53 and cancer.